<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>제약주 on ratiertm</title><link>http://ratiertm.github.io/tags/%EC%A0%9C%EC%95%BD%EC%A3%BC/</link><description>Recent content in 제약주 on ratiertm</description><generator>Hugo -- gohugo.io</generator><language>ko</language><copyright>© 2026 마인드빌드</copyright><lastBuildDate>Mon, 02 Feb 2026 00:00:00 +0000</lastBuildDate><atom:link href="http://ratiertm.github.io/tags/%EC%A0%9C%EC%95%BD%EC%A3%BC/index.xml" rel="self" type="application/rss+xml"/><item><title>애브비(ABBV) 주가 전망: 휴미라 이후 더 강해진 배당 성장주, 지금 살까?</title><link>http://ratiertm.github.io/posts/abbvie-stock-analysis-2026/</link><pubDate>Mon, 02 Feb 2026 00:00:00 +0000</pubDate><guid>http://ratiertm.github.io/posts/abbvie-stock-analysis-2026/</guid><description>&lt;p&gt;&lt;figure&gt;&lt;img
 class="my-0 rounded-md"
 loading="lazy"
 decoding="async"
 fetchpriority="low"
 alt="ABBV 애브비 주식"
 src="http://ratiertm.github.io/images/stocks/ABBV.webp"
 &gt;&lt;/figure&gt;
&lt;/p&gt;

&lt;h2 class="relative group"&gt;휴미라가 무너지면 애브비도 끝? 결과는 정반대였습니다
 &lt;div id="휴미라가-무너지면-애브비도-끝-결과는-정반대였습니다" class="anchor"&gt;&lt;/div&gt;
 
 &lt;span
 class="absolute top-0 w-6 transition-opacity opacity-0 -start-6 not-prose group-hover:opacity-100 select-none"&gt;
 &lt;a class="text-primary-300 dark:text-neutral-700 !no-underline" href="#%ed%9c%b4%eb%af%b8%eb%9d%bc%ea%b0%80-%eb%ac%b4%eb%84%88%ec%a7%80%eb%a9%b4-%ec%95%a0%eb%b8%8c%eb%b9%84%eb%8f%84-%eb%81%9d-%ea%b2%b0%ea%b3%bc%eb%8a%94-%ec%a0%95%eb%b0%98%eb%8c%80%ec%98%80%ec%8a%b5%eb%8b%88%eb%8b%a4" aria-label="앵커"&gt;#&lt;/a&gt;
 &lt;/span&gt;
 
&lt;/h2&gt;
&lt;p&gt;애브비 하면 뭐가 떠오르세요?&lt;/p&gt;
&lt;p&gt;아마 &amp;ldquo;휴미라 특허 만료&amp;rdquo; 아니면 &amp;ldquo;그 배당 잘 주는 제약회사&amp;quot;일 거예요.&lt;/p&gt;</description></item></channel></rss>